Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger’s disease)

Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger’s disease)

Abstract Thromboangiitis obliterans (TAO), also known as Buerger’s Disease, is an occlusive vasculitis linked with high morbidity and amputation risk. To date, TAO is deemed incurable due to the lack of a definitive treatment. The immune system and inflammation are proposed to play a central role in...

Full description

Bibliographic Details
Main Authors: Jorge D. Martin-Rufino, Francisco S. Lozano, Alba M. Redondo, Eva M. Villaron, Raquel Rueda, Rafael Fernandez-Samos, Fermin Sanchez-Guijo
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Stem Cell Research & Therapy
Subjects:
Allogeneic mesenchymal stromal cells
Thromboangiitis obliterans
Cell transplantation
Online Access:http://link.springer.com/article/10.1186/s13287-018-0901-6

Internet

http://link.springer.com/article/10.1186/s13287-018-0901-6

Similar Items